Randeep Guleria Aiims
-
{
- All
- News
- Videos
-
COVID-19 Vaccines Can Be "Tweaked" To Fight New Variants: AIIMS Director Randeep Guleria
The COVID-19 vaccines can be "tweaked" to provide protection against new variants of the virus, All India Institute of Medical Sciences (AIIMS), Delhi, Director Dr Randeep Guleria has said.
-
"India Looks To Vaccinate 1 Crore People Daily By July-End": AIIMS Chief
AIIMS chief Randeep Guleria has said that India must hike vaccine production in a big way and complement it with a holistic global procurement approach to meet its Covid inoculation targets.
-
Herd Immunity Difficult To Achieve: AIIMS Director Randeep Guleria
Herd immunity is "very difficult" to achieve and one should not think of it in "practical terms" in India, especially in the times of "variant strains" of COVID-19 and "waning immunity", claimed AIIMS director Randeep Guleria on Sunday.
-
Number Of Vaccine Doses, Who Pays, Other Queries Answered By AIIMS Chief
A system to differentiate people with comorbidities is in the works to ensure those who are at a higher risk get vaccinated for COVID-19 first, the All India Institute of Medical Sciences (AIIMS) Director Dr Randeep Guleria told NDTV Friday.
-
Huge Gap In Demand, Supply Of Organs For Transplant: AIIMS Chief
There is a "huge gap" in the demand and supply of human organs and tissues for transplant in the country, AIIMS Director Dr Randeep Guleria said today, adding that the myths prevalent in this domain must be busted to ensure that lives are saved by timely availability of vital body parts.
-
COVID-19 Vaccines Can Be "Tweaked" To Fight New Variants: AIIMS Director Randeep Guleria
The COVID-19 vaccines can be "tweaked" to provide protection against new variants of the virus, All India Institute of Medical Sciences (AIIMS), Delhi, Director Dr Randeep Guleria has said.
-
"India Looks To Vaccinate 1 Crore People Daily By July-End": AIIMS Chief
AIIMS chief Randeep Guleria has said that India must hike vaccine production in a big way and complement it with a holistic global procurement approach to meet its Covid inoculation targets.
-
Herd Immunity Difficult To Achieve: AIIMS Director Randeep Guleria
Herd immunity is "very difficult" to achieve and one should not think of it in "practical terms" in India, especially in the times of "variant strains" of COVID-19 and "waning immunity", claimed AIIMS director Randeep Guleria on Sunday.
-
Number Of Vaccine Doses, Who Pays, Other Queries Answered By AIIMS Chief
A system to differentiate people with comorbidities is in the works to ensure those who are at a higher risk get vaccinated for COVID-19 first, the All India Institute of Medical Sciences (AIIMS) Director Dr Randeep Guleria told NDTV Friday.
-
Huge Gap In Demand, Supply Of Organs For Transplant: AIIMS Chief
There is a "huge gap" in the demand and supply of human organs and tissues for transplant in the country, AIIMS Director Dr Randeep Guleria said today, adding that the myths prevalent in this domain must be busted to ensure that lives are saved by timely availability of vital body parts.
